Recent studies have reported direct FGF-23 effects on the heart myocardium, and elevated plasma levels of FGF-23 have been associated with negative CVD outcomes such as arrhythmias and heart failure [8,9]. The gene discussed is FGF23; the disease is cardiac arrhythmia.